Results 171 to 180 of about 133,468 (309)

A febrile papulovesicular rash in a patient with pyoderma gangrenosum

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Anika Rajput Khokhar   +5 more
wiley   +1 more source

Expression of CD38 on resting peripheral iNKT cells defines an immature subpopulation with distinct functionality in humans

open access: yesImmunology &Cell Biology, EarlyView.
In this study, we characterize a distinct subpopulation of undifferentiated invariant natural killer T (iNKT) cells in the peripheral blood of healthy adults, which are characterized by CD38 expression in a resting state. This CD38+ subset closely resembles iNKT cells from cord blood and thymus, exhibiting a unique cytokine profile and alterations in ...
Christopher Menne   +13 more
wiley   +1 more source

Long Term Observation for Immunogenecity of Plasma-Derived Hepatitis B Vaccine and Supplementary Vaccination of Recombinant Vaccine in Infants

open access: diamond, 1988
Jun Hayashi   +8 more
openalex   +2 more sources

Evaluation of immunological response to hepatitis B vaccine among healthcare workers at Rwanda Military Hospital

open access: diamond, 2023
Charles Muhinda   +8 more
openalex   +2 more sources

Scoping Review of Sexual and Gender Minority Health Research in Ireland

open access: yesJournal of Advanced Nursing, EarlyView.
ABSTRACT Aim To map existing sexual and gender minority (SGM) health research in Ireland, identify gaps in literature and outline priorities for future research and healthcare. SGM is an umbrella term that includes people who identify as lesbian, gay, bisexual, transgender, queer or intersex and is sometimes abbreviated as LGBTQI+.
John P. Gilmore   +7 more
wiley   +1 more source

Long-term immunogenicity of hepatitis B vaccine and impact of a booster dose on health care students [PDF]

open access: diamond, 2019
Behzad Bijani   +4 more
openalex   +1 more source

Long‐term safety and efficacy of secukinumab in paediatric severe plaque psoriasis: 236‐week, Phase 3 trial results

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
In this Phase III study, secukinumab demonstrated sustained efficacy and a favourable safety profile in paediatric patients with chronic severe plaque psoriasis over a treatment period of 236 weeks. Abstract Background Plaque psoriasis, a chronic inflammatory disease, affects up to 2.1% of the global paediatric population.
Andrzej Kaszuba   +11 more
wiley   +1 more source

Do we need better hepatitis B vaccines? [PDF]

open access: yesIndian J Med Res, 2017
Gerlich WH.
europepmc   +1 more source

Chip Shots: Association Between the State Children's Health Insurance Programs and Immunization Coverage and Delivery [PDF]

open access: yes
By age two a child who is up to date for immunizations will have received up to 19 shots delivered over eight visits at a market cost of $525 dollars for the vaccines alone, a far more expensive and demanding regimen that the 8 shots received in 1987. In
Andrew Racine, Ted Joyce
core  

French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
New 2025 French guidelines update psoriasis management with revised algorithms integrating recent systemic therapies. They recommend methotrexate, adalimumab or ustekinumab as first‐line treatments and provide guidance for special psoriasis forms, comorbidities, pregnancy and long‐term management.
Marie Masson Regnault   +51 more
wiley   +1 more source

Home - About - Disclaimer - Privacy